Fagan Associates, Inc. Abbott Laboratories Transaction History

Fagan Associates, Inc.

$571 Million
Q3 2024

A detailed history of Fagan Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Fagan Associates, Inc. holds 7,520 shares of ABT stock, worth $894,504. This represents 0.15% of its overall portfolio holdings.

Number of Shares

7,520

Previous 7,520 -0.0%

Holding current value

$894,504

Previous $781,000 9.73%

% of portfolio

0.15%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $10,073 - $11,244	-100 Reduced 1.31%	7,520 $781,000
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $1,095 - $1,209	-10 Reduced 0.13%	7,620 $866,000
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $9,019 - $11,040	-100 Reduced 1.29%	7,630 $839,000
Q3 2023 Oct 31, 2023	SELL	$95.53 - $114.62 $1,624 - $1,948	-17 Reduced 0.22%	7,730 $748,000
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $7,129 - $8,364	-75 Reduced 0.96%	7,747 $0
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $816 - $986	-8 Reduced 0.1%	7,822 $850,000
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $11,402 - $13,904	-100 Reduced 1.26%	7,830 $927,000
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $577 - $707	5 Added 0.06%	7,930 $1.12 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $22,215 - $26,151	-210 Reduced 2.58%	7,925 $919,000
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $70,746 - $83,349	-650 Reduced 7.4%	8,135 $975,000
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $5,775 - $6,293	-55 Reduced 0.62%	8,785 $962,000
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $32,532 - $39,507	355 Added 4.18%	8,840 $962,000
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $37,136 - $47,530	485 Added 6.06%	8,485 $776,000
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $31,724 - $46,389	505 Added 6.74%	8,000 $631,000
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 1.32%	7,495 $651,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $8,184 - $8,874	100 Added 1.33%	7,595 $635,000
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $5,466 - $6,375	-75 Reduced 0.99%	7,495 $630,000
Q2 2018 Aug 06, 2018	BUY	$57.57 - $63.54 $2,878 - $3,177	50 Added 0.66%	7,570 $462,000
Q1 2018 May 08, 2018	SELL	$56.27 - $63.62 $2,813 - $3,181	-50 Reduced 0.66%	7,520 $451,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $15,298 - $16,378	285 Added 3.91%	7,570 $432,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $18,503 - $20,651	385 Added 5.58%	7,285 $389,000
Q2 2017 Aug 07, 2017	BUY	N/A	6,900	6,900 $335,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fagan Associates, Inc. with notifications on news.

Account

Fagan Associates, Inc. Abbott Laboratories Transaction History